Literature DB >> 11106101

Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.

J Yamanaka1, N Yamanaka, K Nakasho, T Tanaka, T Ando, C Yasui, N Kuroda, M Takata, S Maeda, K Matsushita, K Uematsu, E Okamoto.   

Abstract

BACKGROUND AND AIMS: Prognosis after hepatectomy for hepatocellular carcinoma (HCC) has been improved by progress in the evaluation of hepatic functional reserve, surgical techniques and perioperative management. However, even when curative resection is performed at a relatively early stage, a considerable number of patients develop early intrahepatic and/or extrahepatic recurrence postoperatively. This study analyzed the clinicopathologic features of HCC with early recurrence.
METHODS: We reviewed records of 513 consecutive patients who had undergone liver resection for HCC. There were 48 deaths within a year after surgery from recurrence, including 21 patients with stage II or III HCC (group I). Clinicopathologic parameters of group I patients were compared with those of 188 patients (group II) who developed recurrence following resection of stage II or III HCC and died more than 1 year after surgery.
RESULTS: On univariate analysis, age, tumor diameter (phi), alpha-fetoprotein (AFP):phi and protein induced by vitamin K absence or antagonist II (PIVKA-II):phi were significantly greater in group I than in group II. Macroscopic portal vein invasion, microscopic vascular invasion, intrahepatic metastasis, poor differentiation, pleomorphism, sarcomatous change, vascular lake, and angiographic condensed pooling were more frequently observed in group I than group II. Five independent determinants were selected by multivariate analysis: AFP:phi, histologic pleomorphism, sarcomatous change, vascular lake and angiographic condensed pooling.
CONCLUSIONS: Highly malignant HCC with extremely poor prognosis exhibits peculiar clinicopathologic characteristics, particularly histologic immaturity, and can be predicted by preoperative indicators such as markedly elevated tumor marker concentrations and condensed pooling on angiography.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106101     DOI: 10.1046/j.1440-1746.2000.02323.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  19 in total

Review 1.  Moving toward an understanding of the metastatic process in hepatocellular carcinoma.

Authors:  W M Korn
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Ultrasonic aspiration hepatectomy for 136 patients with hepatocellular carcinoma.

Authors:  Wei Wu; Xin-Bao Lin; Jian-Min Qian; Zhen-Ling Ji; Zao Jiang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

3.  Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres.

Authors:  Akihiko Seki; Shinichi Hori; Chigusa Shimono
Journal:  Jpn J Radiol       Date:  2015-10-22       Impact factor: 2.374

Review 4.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 5.  Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC.

Authors:  Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

Review 6.  Direct biliopancreatoduodenal invasion by hepatocellular carcinoma: report of the first resected case and review of the literature.

Authors:  Yutaro Kato; Kentaro Matsubara; Yoshinobu Akiyama; Hiroaki Hattori; Akira Hirata; Tatsuya Yamamoto; Fumio Suzuki; Hitoshi Ohtaka; Yoshiaki Sugiura; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2010-10-21       Impact factor: 3.402

7.  Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation.

Authors:  Shin Hwang; Sung-Gyu Lee; Young-Joo Lee; Chul-Soo Ahn; Ki-Hun Kim; Kwang-Min Park; Ki-Myung Moon; Deok-Bog Moon; Tae-Yong Ha; Eun-Sil Yu; Ga-Won Choi
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

8.  Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.

Authors:  Xiao-Yong Fu; Hong-Yang Wang; Lu Tan; Shu-Qin Liu; Hui-Fang Cao; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.

Authors:  Zheng-Gang Ren; Zhi-Ying Lin; Jing-Lin Xia; Sheng-Long Ye; Zeng-Chen Ma; Qing-Hai Ye; Lun-Xiu Qin; Zhi-Quan Wu; Jia Fan; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

10.  Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis.

Authors:  A Nanashima; Y Sumida; S Tobinaga; K Shibata; H Shindo; M Obatake; S Shibasaki; N Ide; Takeshi Nagayasu
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.